Quantification of anti-Mü llerian hormone (AMH) in dried blood spots: Validation of a minimally invasive method for assessing ovarian reserve

Human Reproduction

Volumn 27, Issue 8, 2012, Pages 2503-2508

  McDade, Thomas W ^a   Woodruff, Teresa K ^b   Huang, Yuan Yen ^a   Funk, William E ^a   Prewitt, Maureen ^c   Kondapalli, Laxmi ^c   Gracia, Clarisa R ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Immunoassay; Infertility; M llerian inhibiting substance; Ovarian follicle; Ovary

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MINIMALLY INVASIVE PROCEDURE; OVARIAN RESERVE; ROOM TEMPERATURE;

EID: 84870018767     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des194     Document Type: Article

References (29)

1. Almog B, Shehata F, Suissa S, Holzer H, Shalom-Paz E, La Marca A, Muttukrishna S, Blazar A, Hackett R, Nelson SM et al. Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 2011;95:2359-2363.
2. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310. (Pubitemid 16134762)
3. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160. (Pubitemid 29425900)
4. Borders AEB, Grobman WA, Amsden LB, Collins ET, Holl JL. Factors that influence the acceptability of collecting in-home finger stick blood samples in an urban, low-income population. J Health Care Poor Underserved 2007;18:100-115.
5. Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91:705-714.
6. Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JTJ, Grootegoed JA, Themmen APN. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-1084. (Pubitemid 34164056)
7. Fauser BCJM, de Vet A, Laven JSE, de Jong FH, Themmen APN. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362. (Pubitemid 34083560)
8. Fong SL, Lugtenburg PJ, Schipper I, Themmen APN, de Jong FH, Sonneveld P, Laven JSE. Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008;23:674-678. (Pubitemid 351651205)
9. Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, Vance A, Ginsberg JP. Impact of cancer therapies on ovarian reserve. Fertil Steril 2012;97:134-140.
10. Harris KM. An integrative approach to health. Demography 2010;47:1-22.
11. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model of serum anti-Mullerian hormone from conception to menopause. PLoS One 2011;6:e22024.
12. Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE. Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51-59.
13. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008;90:737-743.
14. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocr Metab 1996;81:571-576. (Pubitemid 26055665)
15. McDade TW. The state and future of blood-based biomarkers in the Health and Retirement Study. Forum Health Econ Policy 2011; 14.article 5.
16. McDade TW, Shell-Duncan B. Whole blood collected on filter paper provides a minimally invasive method for assessing human transferrin receptor level. J Nutr 2002;132:3760-3763. (Pubitemid 35435060)
17. McDade TW, Stallings JF, Angold A, Costello EJ, Burleson M, Cacioppo JT, Glaser R,Worthman CM. Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. Psychosom Med 2000;62:560-567.
18. McDade TW, Burhop J, Dohnal J. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem 2004; 50:652-654. (Pubitemid 38297322)
19. McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007;44:899-925.
20. McIlveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod 2007;22:778-785.
21. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril 2011;95:747-750.
22. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2007;134:196-201. (Pubitemid 47451601)
23. Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, Baird DD. Antimullerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 2011;117:798-804.
24. Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 2009;16:797-802.
25. van Rooij IAJ, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LFJMM, de Jong FH, Themmen APN. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071. (Pubitemid 35469254)
26. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601-606. (Pubitemid 40353222)
27. Williams SR, McDade TW. The use of dried blood spot sampling in the National Social Life, Health, and Aging Project. J Gerontol B Psychol 2009;64:I131-I136.
28. Worthman CM, Stallings JF. Measurement of gonadotropins in dried blood spots. Clin Chem 1994;40:448-453. (Pubitemid 24097809)
29. Worthman CM, Stallings JF. Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. Am J Phys Anthropol 1997;104:1-22.